Thorsten Haas

Title: Thorsten Haas: Innovator in Hematology

Introduction

Thorsten Haas is a notable inventor based in Oberperfuss, Austria. He has made significant contributions to the field of hematology, particularly in the treatment of bleeding disorders. With a total of 2 patents, his work focuses on innovative solutions for coagulopathy.

Latest Patents

Haas's latest patents include advancements related to von Willebrand factor and factor VIII. His inventions aim to treat and prevent bleeding events associated with thrombopathy induced by substances that inhibit thrombocytes. The first patent describes a von Willebrand Factor for use in treating bleeding events, while the second patent outlines a method for administering a pharmaceutically effective amount of von Willebrand Factor (vWF) to patients in need. Additionally, his work includes compositions comprising vWF and FVIII for simultaneous, separate, or sequential use in treatment.

Career Highlights

Thorsten Haas is associated with Csl Behring GmbH, where he continues to develop innovative treatments for bleeding disorders. His expertise in the field has led to significant advancements that benefit patients suffering from coagulopathy.

Collaborations

Haas collaborates with esteemed colleagues such as Gerhard Dickneite and Ingo Pragst, contributing to a dynamic research environment focused on improving patient outcomes in hematology.

Conclusion

Thorsten Haas is a dedicated inventor whose work in hematology has the potential to transform treatment options for patients with bleeding disorders. His innovative patents and collaborations highlight his commitment to advancing medical science.